Illustration of a healthy skin, sun and skin cells

Sun's Out, Scalp's Out: Unveiling the Revolutionary Treatment for Actinic Keratosis

Nico Varela monogram
Nico Varela in Health & Wellness October 2026 • 4 min read.

"Discover the Latest Breakthrough in Treating Sun-Damaged Skin and Preventing Skin Cancer"


Sunlight, while vital for life, can sometimes be a double-edged sword. While we love a sunny day, the sun's rays can cause significant damage to our skin over time. One of the most common outcomes of this damage is actinic keratosis (AK), a precancerous condition that appears as rough, scaly patches on the skin. If left untreated, AK can potentially develop into skin cancer, making its management a top priority.

Fortunately, medical advancements are constantly providing us with new tools to combat these issues. This article will discuss a recent study that has shown promising results in treating AK. The study focuses on a combination therapy that may change how we approach this common skin condition. Understanding the condition and its treatment options is key to maintaining skin health and preventing more serious problems.

This isn't just about aesthetics; it's about health. Actinic keratosis can be an early warning sign. Early and effective treatment is essential for maintaining skin health and preventing the development of more serious conditions. Let's delve into the latest findings to empower you with knowledge and proactive steps you can take for your skin.

AI Search Multiple angles on this topic

A Common Sun-Related Condition

Actinic keratosis is generally associated with cumulative ultraviolet exposure and commonly appears on sun-exposed skin. It can impose a meaningful disease burden because lesions may be numerous, recurrent, and distributed across broad areas. The condition is clinically important because some lesions may progress to squamous cell carcinoma, although individual risk can vary.

Established Treatment Options

Standard management generally combines lesion-directed and field-directed approaches. Common options include topical medications, cryosurgery, photodynamic therapy, and laser ablation. Selection can be challenging because treatments differ in tolerability, treatment duration, cosmetic effects, and suitability for patients with isolated lesions versus broader field cancerization.

From Recognition to Prevention

The understanding of actinic keratosis has developed alongside recognition of the relationship between chronic sun exposure and premalignant skin change. Earlier management emphasized removing visible lesions, while later approaches also addressed clinically subtle or subclinical disease across sun-damaged fields. This shift helped establish prevention of progression as a central treatment goal.

Calcipotriol-Assisted MAL-PDT: The New Frontier in AK Treatment

Illustration of a healthy skin, sun and skin cells

The study we'll explore investigates a treatment that combines two existing therapies: photodynamic therapy (PDT) and a topical medication called Calcipotriol (CAL). PDT uses light to target and destroy abnormal skin cells. Meanwhile, Calcipotriol is known for its ability to regulate skin cell growth. The research aimed to determine whether the combination of these two treatments would provide better results than using PDT alone, especially for those tricky-to-treat AK lesions on the scalp.

The innovative approach tested in the study involves using Calcipotriol to prepare the skin, followed by PDT to eliminate the affected cells. The goal was to leverage the benefits of each treatment to improve overall outcomes, including higher efficacy and fewer side effects. The study's findings are important because they offer insights into a new treatment approach and how it can improve patient care.

  • Higher Efficacy: The combination therapy showed improved effectiveness in treating AK lesions, particularly on the scalp, compared to PDT alone.
  • Safety Profile: The combination was well-tolerated by patients, indicating a favorable safety profile, though some side effects were more common.
  • Targeted Approach: The study's design focused on addressing AK lesions, providing a targeted approach to skin treatment.
AI Search Multiple angles on this topic

Reviews Refine the Treatment Algorithm

Recent reviews present treatment algorithms adapted from the European consensus-based interdisciplinary guideline for the diagnosis, treatment, and prevention of actinic keratoses. A June 2024 review reported that a systematic literature review and network meta-analysis found 5% fluorouracil interventions had the best efficacy and a satisfactory acceptability profile among field-directed therapies. A January 2025 comprehensive review likewise examined current treatments alongside emerging therapeutic options, reflecting continued expansion of the AK treatment landscape.

Why Treatment Is Not One-Size-Fits-All

Actinic keratosis is a chronic disease in which clinical and subclinical lesions can coexist on sun-exposed areas, including the head, neck, and extremities. This field-wide pattern means that treating a visible lesion may not address all affected skin. Current guidance therefore includes multiple options, such as topical medications, photodynamic therapy, cryosurgery, and laser ablation, while emphasizing individualized decisions based on lesion burden and the extent of field cancerization.

Fluorouracil Leads a Four-Way Trial

In a randomized trial of four field-directed treatment approaches for patients with multiple actinic keratoses on the head, 5% fluorouracil cream was the most effective treatment at 12 months after treatment ended. The result provides direct comparative evidence favoring fluorouracil in that study population and follow-up period. It does not by itself establish that the same treatment is optimal for every patient or clinical setting.

By combining these two proven methods, researchers have discovered a potentially more effective strategy for treating AK. This combined method offers a targeted way to combat the condition. This approach reduces the need for more invasive treatments, making the process more comfortable and efficient for patients. This innovative therapy is not just an upgrade; it is a more thoughtful strategy for maintaining healthy skin.

Protecting Your Skin: A Proactive Approach

This study highlights how the combination of Calcipotriol and PDT offers a promising solution for those dealing with AK, especially on the scalp. The study's results highlight a shift towards personalized, effective treatments. If you're concerned about AK or sun-damaged skin, consult with a dermatologist. Early detection and effective treatments can help you. Protect your skin today by wearing sunscreen. Seek advice from experts to embrace a future of healthy and radiant skin.

AI Search Multiple angles on this topic

Consensus Places PDT in Context

A 2017 structured consensus statement used a three-round Delphi procedure followed by a consensus meeting involving 16 clinical experts from 13 countries. The process produced a structured consensus statement and treatment algorithm positioning daylight photodynamic therapy among other options for actinic keratosis. A 2025 expert consensus similarly addressed the need for clearer and more detailed guidance on photodynamic therapy because existing guidelines were described as controversial and incomplete.

Toward More Precise Management

Recent work describes progress in actinic keratosis management across therapeutic breakthroughs, pathophysiology, and program implementation. The Dermatologic Clinics review highlights advances in photodynamic therapy, new topical treatments, and genomic and transcriptomic pathways involved in progression from actinic keratosis to squamous cell carcinoma. Market commentary also projects continued technology adoption aimed at improving treatment precision, patient comfort, and clinical outcomes, although such projections are not clinical evidence.

A Global Premalignant Burden

The State of the Art review describes actinic keratosis as an early phase of squamous cell carcinoma and one of the most common epithelial skin lesions. It estimates global prevalence at approximately 14% and discusses an annual risk of progression. These figures frame AK as a broad public-health and prevention challenge rather than solely a problem of individual lesions.

Treatment in Everyday Practice

Real-world research is examining how patient and lesion characteristics relate to treatment choices and clinical outcomes over the long term. A retrospective study specifically investigated these correlations in routine care, while another real-world study reported that tirbanibulin 1% ointment significantly reduced the actinic keratosis area and severity index in patients with AK. A separate retrospective chart review noted that comparative real-world data remain limited for lesion-directed and field-directed treatments, including combination use.

What the scalp study adds in plain terms

The reported advantage was not simply a general claim about all lesions: the authors singled out thicker AK lesions as a setting where the combination was especially effective. The finding supports a possible role for calcipotriol-assisted PDT in that context, but does not establish how durable the benefit is beyond the monitored period.[1]

A split-scalp comparison of calcipotriol-assisted MAL-PDT

SettingScalp[1]
Duration3 months[1]
ComparisonPDT alone[1]
Times cited0[1]

How the scalp comparison fits with other PDT evidence

This study compared calcipotriol-assisted treatment with PDT alone on opposite sides of the scalp, while a separate daylight PDT trial compared daylight treatment with conventional PDT and found non-inferiority for complete lesion response at week twelve. These are different treatment comparisons, so the daylight result does not directly confirm the calcipotriol add-on effect.[1] [2]

Other PDT comparisons report high clearance in particular settings, including facial or mild lesions, underscoring that outcomes vary with the treatment and lesion context rather than providing a direct benchmark for this scalp study.[3] [4]

A review describes daylight PDT as better tolerated than conventional illumination, while another notes that calcipotriol pretreatment may intensify redness and scaling. Together, these sources point to a balance between treatment effect and local reaction, not a settled tolerability advantage for the combination studied here.[5] [6]

What a follow-up study would need to clarify

  • Would the apparent advantage for thicker lesions persist with a larger scalp study and longer monitoring?[1] [7]
  • How do microscopic changes on the calcipotriol-assisted side relate to clinical lesion response across more patients?[7] [8]

Terms used in the scalp comparison

Actinic keratosis
A common premalignant skin lesion that can progress to squamous cell carcinoma.[1]

Sources

  1. Calcipotriol-assisted vs. conventional MAL-PDT in actinic keratosis (Oxford University Press (OUP), 2018)
  2. Daylight photodynamic therapy with methyl aminolevulinate cream as a convenient, similarly effective, nearly painless alternative to conventional photodynamic therapy in actinic keratosis treatment: a (pubmed.ncbi.nlm.nih.gov)
  3. A randomized, intraindividual, non‐inferiority, Phase III study comparing daylight photodynamic therapy with BF‐200 ALA gel and MAL cream for the treatment of actinic keratosis (pmc.ncbi.nlm.nih.gov)
  4. Review of photodynamic therapy in actinic keratosis and basal cell carcinoma (pmc.ncbi.nlm.nih.gov)
  5. Topical Immunotherapy for Actinic Keratosis and Field Cancerization (pmc.ncbi.nlm.nih.gov)
  6. Daylight Photodynamic Therapy: An Update (pmc.ncbi.nlm.nih.gov)
  7. A 12-month follow-up split-scalp study comparing calcipotriol-assisted MAL-PDT with conventional MAL-PDT for the treatment of actinic keratosis: a randomized controlled trial. (pubmed.ncbi.nlm.nih.gov)
  8. A randomized split-scalp study comparing calcipotriol-assisted methyl aminolaevulinate photodynamic therapy (MAL-PDT) with conventional MAL-PDT for the treatment of actinic keratosis. (pubmed.ncbi.nlm.nih.gov)

About this Article -

Written with AI assistance from published research, and reviewed by the Mystum team. See our About page for more information.

This article is based on research published under:

DOI-LINK: 10.1111/bjd.17162, Alternate LINK

Title: Calcipotriol-Assisted Vs. Conventional Mal-Pdt In Actinic Keratosis

Subject: Dermatology

Journal: British Journal of Dermatology

Publisher: Wiley

Authors: L. Torezan, B. Grinblat, M. Haedersdal, N. Valente, C. Festa-Neto, R.M. Szeimies

Published: 2018-10-01

Everything You Need To Know

1

What is actinic keratosis (AK), and why is it important to treat?

Actinic keratosis (AK) is a common skin condition caused by sun exposure. It appears as rough, scaly patches on the skin and is considered precancerous. If left untreated, actinic keratosis can potentially develop into skin cancer. Therefore, management is a top priority for maintaining skin health and preventing more serious problems. Early and effective treatment of actinic keratosis is essential for stopping the progression into more severe conditions. While the text highlights treatment, it doesn't delve into diagnostic methods, such as biopsies, which are crucial for confirming the diagnosis. Furthermore, it does not cover the various stages or grading of actinic keratosis, which influence treatment decisions.

2

How does the combination therapy of Calcipotriol and photodynamic therapy (PDT) work to treat actinic keratosis?

The combination therapy of Calcipotriol and photodynamic therapy (PDT) works by leveraging the benefits of each treatment to improve overall outcomes for actinic keratosis. First, Calcipotriol, a topical medication known for regulating skin cell growth, is used to prepare the skin. Then, photodynamic therapy (PDT) uses light to target and destroy the abnormal skin cells affected by actinic keratosis. The research aimed to determine whether combining these two treatments provides better results than using photodynamic therapy (PDT) alone, especially for actinic keratosis lesions that are hard to treat, such as those on the scalp. While the basic mechanism is provided, the text omits the specific molecular pathways through which Calcipotriol modulates skin cell growth or the photosensitizing agents used in photodynamic therapy (PDT) and their mechanism of action when exposed to light.

3

What were the main findings of the study on Calcipotriol-assisted MAL-PDT for treating actinic keratosis?

The study showed that the combination of Calcipotriol and photodynamic therapy (PDT) improved effectiveness in treating actinic keratosis lesions, particularly on the scalp, compared to photodynamic therapy (PDT) alone. The combination was also well-tolerated by patients, indicating a favorable safety profile, although some side effects were more common. The study provided a targeted approach to treating actinic keratosis on the skin. However, the text does not provide specific data on the percentage of improvement or the types and severity of side effects observed. It also doesn't compare this treatment against other common actinic keratosis treatments, such as cryotherapy or topical medications like 5-fluorouracil or imiquimod, in terms of efficacy, cost, and patient convenience.

4

What are the implications of using Calcipotriol and photodynamic therapy (PDT) combination as a treatment for actinic keratosis?

The implications of using the Calcipotriol and photodynamic therapy (PDT) combination for treating actinic keratosis include higher efficacy compared to photodynamic therapy (PDT) alone. This means that patients may experience better clearance of actinic keratosis lesions, especially in difficult-to-treat areas like the scalp. Additionally, the treatment is well-tolerated, suggesting a good safety profile. This combination offers a targeted approach, reducing the need for more invasive treatments. However, the text doesn't explore long-term outcomes, such as recurrence rates or the potential for preventing the progression to skin cancer. Furthermore, it doesn't discuss the cost-effectiveness of this combination compared to other treatments or the accessibility of photodynamic therapy (PDT) in various clinical settings.

5

Besides treatment, what else can be done to protect skin and prevent actinic keratosis?

To protect the skin and prevent actinic keratosis, wearing sunscreen is crucial. Regular consultations with a dermatologist are also recommended for early detection and effective treatments. Early and effective treatment is essential for maintaining skin health and preventing the development of more serious conditions. This proactive approach helps maintain healthy and radiant skin. While the importance of sunscreen is mentioned, the text doesn't elaborate on the specific types of sunscreen (e.g., mineral vs. chemical), the recommended SPF levels, or the importance of reapplication. It also doesn't discuss other preventive measures, such as wearing protective clothing (hats, long sleeves) or avoiding peak sun hours. Lifestyle changes and dietary considerations that could potentially reduce the risk of actinic keratosis are also not mentioned.

Newsletter Subscribe

Subscribe to get the latest articles and insights directly in your inbox.